Understanding how gene networks in oligodendrocytes affect cognitive disorders
Prediction and Validation of Oligodendrocyte Gene Regulatory Network from Multi-Omics
This study is looking at how certain genes affect brain cells that are important for thinking and learning, and it aims to help people with developmental disabilities by finding better ways to diagnose and treat their conditions.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-10509768 on NIH RePORTER |
What this research studies
This research investigates the genetic factors influencing oligodendrocytes, which are crucial for brain health and cognitive function. By analyzing multi-omics data, the study aims to create a predictive model that links genetic variations to developmental disabilities and cognitive disorders. The approach involves integrating various datasets to understand how specific gene mutations affect the function of oligodendrocytes and contribute to white matter changes in the brain. Patients with developmental disabilities may benefit from insights gained through this research, potentially leading to better diagnostic and therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with developmental disabilities or cognitive disorders, particularly those with known genetic mutations affecting oligodendrocytes.
Not a fit: Patients without cognitive disorders or developmental disabilities, or those not carrying relevant genetic mutations, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with cognitive disorders linked to oligodendrocyte dysfunction.
How similar studies have performed: Previous research has shown promise in understanding genetic factors in cognitive disorders, but this specific approach integrating multi-omics data is relatively novel.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Svaren, John P — University of Wisconsin-Madison
- Study coordinator: Svaren, John P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.